Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Clinical trial NCT02206204 · COMPLETED

Trial details

NCT number: NCT02206204
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiodynamics Safety Tolerability Pharmacokinetics

Start date: 2012-06-01
Primary completion: 2012-11-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.